Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

SEC Filings

SEC Filings

Filing date Form Description Filing Group Downloads
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
SD

Specialized Disclosure Report

Other

Copyright Morningstar

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)